BRCA 1/2 Mutation in Korean Patients With Epithelial Ovarian Cancer

NCT02963688 · clinicaltrials.gov ↗

COMPLETED

Status

298

Enrollment

OTHER

Sponsor class

Conditions

To Investigate the Prevalence of BRCA 1/2 Mutation Among Ovarian Cancer

Interventions

GENETIC: Ion AmpliSeq BRCA 1/2 Panel (Life Technologies, Carlsbad, CA, USA) ,Ion PGM platform

Sponsor

Samsung Medical Center

Collaborators

[object Object]